We found that intermittent short-duration reoxygenation relieved pulmonary hypertension via NOX4/H2O2/PPAR-γ axis and further reducing non-NOX4 dereived H2O2 could further alleviated hypoxic pulmonary hypertension. This evidence concerns the gene PPARG and pulmonary arterial hypertension.